|
Monday, March 24 — 8:00 AM — Marriott Salon 1
Click on the numbers in parentheses to display abstracts.
Section A - HEMATOPATHOLOGY
Chaired by: John Anastasi and Catherine Listinsky
| 8:00 |
Transcriptional Profiling of MALT Lymphoma: Insight into the Oncogenic Pathway Affected by t(11;18)(q21;q21) and t(1;14)(p22;q32)
(1056)
M-Q Du, RA Hamoudi, H Ye, PG Isaacson
University College London, London, United Kingdom
|
| 8:15 |
t(14;18)(q32;q21) Involving IGH and MALT1 Is a Frequent Chromosomal Aberration in Malt Lymphoma
(1158)
B Streubel, L Cerroni, G Ott, M Raderer, A Chott
University of Vienna, Vienna; University of Graz, Graz, Styria, Austria; University of Wuerzburg, Wuerzburg, Bavaria, Germany
|
| 8:30 |
Histological and Clinical Prognostic Factors in Follicular Lymphoma
(1029)
C M Bacon, I Avivi, EC Obermann, W Qian, P Smith, D Linch, A Dogan
UCL Hospitals; MRC Clinical Trials Unit, London, United Kingdom
|
| 8:45 |
A Clinicopathologic Evaluation of Follicular Lymphoma Grade IIIA vs. IIIB Reveals No Survival Differences
(1080)
ED Hsi, I Mirza, G Lozanski, J Hill, B Pohlman, MT Karafa, RW Coupland
Cleveland Clinic, Cleveland, OH; University of Alberta, Edmonton, AB, Canada; Cross Cancer Institute, Edmonton, AB, Canada
|
| 9:00 |
Investigation of Pro-Survival Pathways by Reverse Phase Protein Microarray in Follicular Lymphoma
(1190)
H Zha, M Raffeld, L Charboneau, S Pittaluga, LA Liotta, E Petricoin III, LW Kwak, ES Jaffe
National Cancer Institute, Bethesda, MD; Food and Drug Administration, Bethesda, MD
|
| 9:15 |
Gene Expression Profiles in AIDS-Related Lymphomas (ARL)
(1048)
S deVos, HP Koeffler, JW Said
UCLA School of Medicine, Los Angeles, CA
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
|
| 11:00 |
Prognostic Significance of STAT3 Activation in Systemic Anaplastic Large Cell Lymphoma
(1094)
JD Khoury, LJ Medeiros, GZ Rassidakis, P Tsioli, V Leventaki, A Schmitt-Graeff, M Herling, AH Sarris, R Lai
M.D. Anderson Cancer Center, Houston, TX; University of Freiburg, Freiburg, Germany
|
| 11:15 |
Detection of the C-Myc Oncogene Translocation and Protein Expression in Burkitt and Other Non-Burkitt Lymphomas
(1043)
W-S Chu, R Wu, S Fisher, MQ Wei, J Zhao, A Marquez, Z Shi, N Aguilera, SL Abbondanzo
Armed Forces Institute of Pathology, WA; R&D, Zymed Laboratories, CA
|
| 11:30 |
Cytogenetic Abnormalities in Post-Transplant Lymphoproliferative Disorder (PTLD)
(1051)
M Djokic, D Liebowitz, MM LeBeau, J Anastasi, K Carlson
University of Chicago, Chicago, IL
|
| 11:45 |
Epidermal Growth Factor Receptor Expression in Follicular Dendritic Cell Sarcoma and Non-Neoplastic Follicular Dendritic Cells
(1160)
X Sun, K Chang, LV Abruzzo, R Lai, A Younes, D Jones
University of Texas M.D. Anderson Cancer Center, Houston, TX
|
|
|
